Pluristem Therapeutic Free Cash Flow (Quarterly):-5.557M for Sept. 30, 2013
View 4,000+ financial data types
Pluristem Therapeutic Free Cash Flow (Quarterly) Chart
Pluristem Therapeutic Historical Free Cash Flow (Quarterly) DataPro Export Data Date Range:
|Data for this Date Range|
|Sept. 30, 2013||-5.557M|
|June 30, 2013||-6.075M|
|March 31, 2013||-4.893M|
|Dec. 31, 2012||-4.728M|
|Sept. 30, 2012||-5.50M|
|June 30, 2012||-1.097M|
|March 31, 2012||-2.836M|
|Dec. 31, 2011||-4.104M|
|Sept. 30, 2011||3.282M|
There is no data for the selected date range.
About Free Cash Flow
Free cash flow is the amount of cash generated by a business that is available for distribution among its security holders. Security holders include debt holders, equity holders, preferred stock holders, and convertible security holders. Specifically, free cash flow is used to pay dividends, make acquisitions, develop new products, invest in new property, plant and equipment, pay interest expenses, and reduce debt.
According to many investors, free cash flow is the best indication of a company's ability to generate cash.
PSTI Free Cash Flow (Quarterly) Benchmarks
PSTI Free Cash Flow (Quarterly) Range, Past 5 Years
GlobeNewswire Nov 4